Biography
Wieselthaler, a native of Austria, earned a medical degree at the University of Vienna, where he completed a residency and surgical training. He also completed advanced training in transplantation at the Vienna heart transplant and lung transplant programs.
Wieselthaler has been involved in the development of ventricular assist pumps and a total artificial heart. He has trained surgeons worldwide in implantation techniques and the use of VADs, and he has published numerous articles in peer-reviewed journals.
Wieselthaler is a member of many national and international medical societies. He is president-elect of the International Society for Rotary Blood Pumps. He is on the board of the European Society for Artificial Organs and former president of the Austrian Society for Implantology and Tissue Integrated Prosthesis. In April 2011, he was named director of the International Society for Heart and Lung Transplantation.
Read a Q&A with Wieselthaler.
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
University of California | Diversity, Equity, and Inclusion Champion Training | 2018 | |
University of Vienna | M.D. | School of Medicine | 1987 |
Clinical Expertise
Acute Aortic Dissection Repair
Aortic Valve Repair & Replacement
Off-Pump Coronary Artery Bypass (OBCAB)
Coronary Artery Bypass Grafting (CABG)
End Stage Heart Failure
Heart Transplantation
Minimally Invasive Cardiac Surgery
Minimally Invasive Valve Surgery
Mitral Valve Repair & Replacement
Myocardial Revascularization Surgery
Thoracic Aneurysm Repair
Thoracic Aortic Reconstruction
Ventricular Aneurysm
Ventricular Assist Devices (VAD)
Arrhythmia
Program Affiliations
UCSF Heart & Vascular Center
In the News
Research Narrative
In 1984, while still in medical school, Dr. Wieselthaler became involved in the Ventricular Assist Device (VAD) Program at the University of Vienna and began working in the Biomedical Laboratory on the development of the driving unit for the "New Vienna Total Artificial Heart (TAH)". After graduation, Dr. Wieselthaler became aware of the advantages of rotary blood pumps and organized the world´s the first "International Workshop(s) on Rotary Blood Pumps" in the years 1988 and 1991 in Austria. Out of these meetings, the International Society for Rotary Blood Pumps was founded in 1992 with Dr. Wieselthaler acting as Secretary General for the organization for many years.
Dr. Wieselthaler and colleague Dr. Heinrich Schima, a biomedical engineer, then investigated and developed miniaturized centrifugal pumps over15 years in the Biomedical Laboratories of the University of Vienna. Dr. Wieselthaler thereafter became primary surgeon at the Medical University of Vienna where implanted various types of VAD systems and supervised patient care. He developed extensive expertise with pulsatile systems like Novacor LVAS and has had one of the longest supported patients on the device (over 4 1/2 years). He also developed the Thoratec paracorporeal and implantable VADs. One of his patients was supported more than 3 years on the world´s first full implantable VAD in the Arrow LionHeart CUPS Trial.
In 1998, Dr. Wieselthaler implanted the world's first implantable, miniaturized axial flow pumps, the MicroMed-DeBakey VAD and he has since implanted more than 80 patients with this device. Many of Dr. Wieselthaler´s leading scientific papers originated his early experience with the world´s first nonpulsatile pump, articles still cited by colleagues. Dr. Wieselthaler also served as Principal Investigator and implanted the world´s first implantable, magnetically suspended centrifugal left ventricular assist device (LVAD), the "TERUMO DuraHeart LVAD".
In 2003, Dr. Wieselthaler joined a HeartWare Inc, Miramar, FL as a consultant and over the next three years, played a key role in the development the HeartWare HVAD, a miniaturized hydromagnatically levitated centrifugal pump. and in 2006, he implanted the world's first patients with this system.
Dr. Wieselthaler continued working with HeartWare on the next generation LVAD, known as the "Miniaturised Ventricular Assist Device (MVAD)", leading to two patent applications in his name for the technology: 1) a minimally invasive implantation technique of the MVAD, and 2) a special shaped inflow cannula tip for the MVAD.
Research Interests
Ventricular Assist Devices (VAD)
Publications
- Late Right Heart Failure After Left Ventricular Assist Device Implantation: Contemporary Insights and Future Perspectives.| | PubMed
- Left ventricular thrombus with extracorporeal membrane oxygenation: Novel technique of bronchoscope-guided thrombus retrieval.| | PubMed
- Time in Therapeutic Range Significantly Impacts Survival and Adverse Events in Destination Therapy Patients.| | PubMed
- Two-Year Follow Up of the LATERAL Clinical Trial: A Focus on Adverse Events.| | PubMed
- Cost of Thoracotomy Approach: An Analysis of the LATERAL Trial.| | PubMed
- Detecting Suspected Pump Thrombosis in Left Ventricular Assist Devices via Acoustic Analysis.| | PubMed
- Evaluation of a lateral thoracotomy implant approach for a centrifugal-flow left ventricular assist device: The LATERAL clinical trial.| | PubMed
- Feasibility and utility of intraoperative epicardial scar characterization during left ventricular assist device implantation.| | PubMed
- Cast of the Right Bronchial Tree.| | PubMed
- Giant right coronary artery aneurysm presenting as cardiac tamponade.| | PubMed